Comparison of the diagnostic and prognostic value of criteria for immune checkpoint inhibitor related myocarditis
The ESC-ICOS guidelines were more restrictive than the Bonaca et al. criteria for the diagnosis of ICIrM but similar in terms of prognostic value.
Authors
- Milagros Pereyra (ORCID: https://orcid.org/0000-0003-4695-8436)
- Chadi Ayoub (ORCID: https://orcid.org/0000-0001-5877-7478)
- Ahmed K. Mahmoud
- Courtney Kenyon (ORCID: https://orcid.org/0009-0007-8511-4347)
- Niloofar Javadi (ORCID: https://orcid.org/0000-0002-3613-0590)
- Reza Arsanjani (ORCID: https://orcid.org/0000-0001-7081-4286)
- Isabel G. Scalia (ORCID: https://orcid.org/0000-0002-6459-9767)
- Carolyn Larsen (ORCID: https://orcid.org/0000-0001-6530-3545)
- Juan Farina (ORCID: https://orcid.org/0000-0002-5824-8485)
- Nadera N. Bismee
- Cecilia Tagle‐Cornell
- Beman Wasef
- Nima Baba Ali
- Mohammed Tiseer Abbas
- Sandra M. Herrmann (ORCID: https://orcid.org/0000-0002-3700-4537)
- Michael C. Roarke
- Kamal A. Awad
Institutions
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1186/s40959-025-00327-4
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09